Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Echocardiography, Three-Dimensional | 27 | 2022 | 591 | 5.520 |
Why?
|
Echocardiography, Transesophageal | 38 | 2022 | 1133 | 5.120 |
Why?
|
Mitral Valve Insufficiency | 21 | 2023 | 1422 | 4.230 |
Why?
|
Mitral Valve | 25 | 2023 | 1491 | 4.150 |
Why?
|
Mitral Valve Annuloplasty | 9 | 2022 | 143 | 2.640 |
Why?
|
Heart Valve Prosthesis | 17 | 2023 | 1488 | 2.200 |
Why?
|
Coronary Artery Bypass | 25 | 2022 | 2289 | 2.140 |
Why?
|
Heart Valve Prosthesis Implantation | 18 | 2020 | 1536 | 1.990 |
Why?
|
Monitoring, Intraoperative | 12 | 2019 | 957 | 1.880 |
Why?
|
Tricuspid Valve Insufficiency | 7 | 2021 | 349 | 1.850 |
Why?
|
Aortic Valve Stenosis | 20 | 2023 | 1965 | 1.560 |
Why?
|
Cardiopulmonary Bypass | 22 | 2020 | 1066 | 1.400 |
Why?
|
Tricuspid Valve | 7 | 2021 | 403 | 1.380 |
Why?
|
Cardiac Surgical Procedures | 26 | 2023 | 3537 | 1.360 |
Why?
|
Aortic Valve | 19 | 2023 | 1922 | 1.350 |
Why?
|
Atrial Appendage | 6 | 2020 | 283 | 1.330 |
Why?
|
Myocardial Ischemia | 8 | 2023 | 2148 | 1.120 |
Why?
|
Heart Valve Diseases | 5 | 2021 | 1073 | 1.090 |
Why?
|
Aortic Valve Insufficiency | 5 | 2023 | 579 | 1.060 |
Why?
|
Echocardiography | 17 | 2022 | 5102 | 0.980 |
Why?
|
Models, Anatomic | 2 | 2019 | 691 | 0.900 |
Why?
|
Coronary Artery Disease | 8 | 2023 | 6487 | 0.840 |
Why?
|
Mitral Valve Stenosis | 4 | 2018 | 376 | 0.780 |
Why?
|
Heart Arrest, Induced | 6 | 2011 | 355 | 0.750 |
Why?
|
Atrial Fibrillation | 9 | 2022 | 5034 | 0.670 |
Why?
|
Heart Murmurs | 1 | 2018 | 94 | 0.620 |
Why?
|
Blood Transfusion | 1 | 2022 | 1301 | 0.540 |
Why?
|
Ventricular Function, Right | 1 | 2020 | 591 | 0.540 |
Why?
|
Echocardiography, Doppler, Color | 5 | 2019 | 364 | 0.500 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 581 | 0.490 |
Why?
|
Ventricular Function | 2 | 2013 | 416 | 0.480 |
Why?
|
Aged | 88 | 2023 | 163280 | 0.430 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2010 | 1873 | 0.420 |
Why?
|
Respiration, Artificial | 2 | 2023 | 2569 | 0.420 |
Why?
|
Humans | 148 | 2023 | 744343 | 0.420 |
Why?
|
Bioprosthesis | 4 | 2023 | 596 | 0.420 |
Why?
|
Chest Pain | 1 | 2019 | 1114 | 0.410 |
Why?
|
Myocardium | 10 | 2020 | 4776 | 0.410 |
Why?
|
Arterioles | 6 | 2011 | 254 | 0.390 |
Why?
|
Prosthesis Design | 9 | 2023 | 2110 | 0.390 |
Why?
|
Imaging, Three-Dimensional | 3 | 2019 | 4042 | 0.380 |
Why?
|
Chest Tubes | 1 | 2011 | 150 | 0.380 |
Why?
|
Intraoperative Care | 5 | 2021 | 767 | 0.370 |
Why?
|
Databases, Factual | 4 | 2021 | 7729 | 0.360 |
Why?
|
Postoperative Complications | 17 | 2023 | 15295 | 0.340 |
Why?
|
Male | 96 | 2023 | 350118 | 0.340 |
Why?
|
Hemodynamics | 13 | 2019 | 4199 | 0.340 |
Why?
|
Myocardial Revascularization | 2 | 2016 | 841 | 0.340 |
Why?
|
Aortic Aneurysm | 4 | 2014 | 643 | 0.330 |
Why?
|
Female | 93 | 2023 | 380194 | 0.330 |
Why?
|
Aorta | 4 | 2016 | 2061 | 0.320 |
Why?
|
Oxidative Stress | 6 | 2020 | 3086 | 0.310 |
Why?
|
Pneumothorax | 1 | 2011 | 379 | 0.310 |
Why?
|
Heart Valves | 2 | 2021 | 291 | 0.300 |
Why?
|
Neuropeptide Y | 3 | 2013 | 200 | 0.300 |
Why?
|
Heart Diseases | 7 | 2018 | 2788 | 0.300 |
Why?
|
Accidental Falls | 1 | 2015 | 1062 | 0.300 |
Why?
|
Image Processing, Computer-Assisted | 7 | 2017 | 8949 | 0.290 |
Why?
|
Recovery of Function | 7 | 2019 | 2925 | 0.280 |
Why?
|
Aged, 80 and over | 26 | 2023 | 57776 | 0.270 |
Why?
|
Delirium | 4 | 2020 | 1609 | 0.270 |
Why?
|
Acidosis | 1 | 2008 | 270 | 0.270 |
Why?
|
Treatment Outcome | 31 | 2023 | 63114 | 0.260 |
Why?
|
Vasoconstriction | 5 | 2011 | 597 | 0.260 |
Why?
|
Middle Aged | 57 | 2021 | 213383 | 0.250 |
Why?
|
Potassium Channels, Calcium-Activated | 3 | 2009 | 49 | 0.250 |
Why?
|
Radiography, Thoracic | 1 | 2011 | 1265 | 0.250 |
Why?
|
Geriatric Assessment | 4 | 2021 | 1372 | 0.250 |
Why?
|
Prosthesis Failure | 3 | 2019 | 1206 | 0.240 |
Why?
|
Endothelin-1 | 3 | 2010 | 314 | 0.240 |
Why?
|
Clinical Competence | 2 | 2019 | 4687 | 0.240 |
Why?
|
Cardiovascular Surgical Procedures | 2 | 2017 | 194 | 0.240 |
Why?
|
Cardiac Tamponade | 2 | 2002 | 173 | 0.240 |
Why?
|
Postoperative Period | 5 | 2020 | 1842 | 0.240 |
Why?
|
Coronary Circulation | 4 | 2012 | 1572 | 0.230 |
Why?
|
Coronary Vessels | 8 | 2015 | 3107 | 0.230 |
Why?
|
Prospective Studies | 24 | 2023 | 53288 | 0.230 |
Why?
|
Retrospective Studies | 25 | 2023 | 77449 | 0.230 |
Why?
|
Receptors, Neuropeptide Y | 3 | 2012 | 44 | 0.230 |
Why?
|
Heart Ventricles | 6 | 2016 | 3821 | 0.230 |
Why?
|
Neostigmine | 1 | 2023 | 69 | 0.220 |
Why?
|
Myocytes, Cardiac | 3 | 2013 | 1637 | 0.220 |
Why?
|
Heart Failure | 3 | 2022 | 10900 | 0.220 |
Why?
|
Ischemia | 3 | 2022 | 1907 | 0.210 |
Why?
|
Aneurysm, False | 2 | 2011 | 276 | 0.210 |
Why?
|
Intraoperative Complications | 2 | 2016 | 1198 | 0.210 |
Why?
|
Protein Kinase C-alpha | 4 | 2010 | 112 | 0.210 |
Why?
|
Catheterization, Central Venous | 1 | 2007 | 514 | 0.210 |
Why?
|
Intraoperative Period | 2 | 2013 | 520 | 0.210 |
Why?
|
Thromboxane A2 | 2 | 2011 | 92 | 0.200 |
Why?
|
Artificial Intelligence | 3 | 2020 | 2214 | 0.200 |
Why?
|
Heart Aneurysm | 2 | 2012 | 120 | 0.200 |
Why?
|
Reperfusion Injury | 1 | 2008 | 1026 | 0.190 |
Why?
|
Drug-Eluting Stents | 2 | 2023 | 753 | 0.190 |
Why?
|
Acid-Base Equilibrium | 1 | 2001 | 185 | 0.190 |
Why?
|
Cardioplegic Solutions | 1 | 2001 | 118 | 0.190 |
Why?
|
Online Systems | 1 | 2001 | 184 | 0.190 |
Why?
|
Methyl Ethers | 1 | 2022 | 205 | 0.190 |
Why?
|
RNA | 3 | 2020 | 2749 | 0.180 |
Why?
|
Length of Stay | 4 | 2023 | 6309 | 0.170 |
Why?
|
Stroke | 8 | 2023 | 9981 | 0.170 |
Why?
|
Rheumatic Heart Disease | 3 | 2010 | 177 | 0.170 |
Why?
|
Risk Factors | 27 | 2023 | 72290 | 0.170 |
Why?
|
Microcirculation | 5 | 2010 | 1286 | 0.170 |
Why?
|
Amiodarone | 1 | 2020 | 212 | 0.160 |
Why?
|
Aneurysm, Infected | 1 | 1998 | 85 | 0.160 |
Why?
|
Thiamine | 2 | 2016 | 152 | 0.160 |
Why?
|
Risk Assessment | 13 | 2023 | 23338 | 0.160 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2021 | 367 | 0.150 |
Why?
|
Erythrocyte Transfusion | 1 | 2022 | 565 | 0.150 |
Why?
|
Biosynthetic Pathways | 1 | 2018 | 137 | 0.150 |
Why?
|
Heart-Assist Devices | 3 | 2023 | 1194 | 0.150 |
Why?
|
Pericardium | 2 | 2018 | 667 | 0.150 |
Why?
|
Muscle, Skeletal | 6 | 2011 | 4931 | 0.150 |
Why?
|
Muscle Contraction | 3 | 2011 | 1240 | 0.150 |
Why?
|
Diabetes Mellitus | 4 | 2020 | 5751 | 0.150 |
Why?
|
Reproducibility of Results | 7 | 2020 | 19905 | 0.150 |
Why?
|
Lung Injury | 1 | 2022 | 436 | 0.150 |
Why?
|
Cardiomyopathies | 2 | 2008 | 1912 | 0.150 |
Why?
|
Anesthetics, Inhalation | 1 | 2022 | 570 | 0.140 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2008 | 2073 | 0.140 |
Why?
|
Feasibility Studies | 6 | 2020 | 5078 | 0.140 |
Why?
|
Hypercholesterolemia | 2 | 2013 | 1151 | 0.140 |
Why?
|
Lactic Acid | 3 | 2016 | 1133 | 0.130 |
Why?
|
Propofol | 1 | 2022 | 629 | 0.130 |
Why?
|
Mitochondria, Heart | 1 | 2017 | 247 | 0.130 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2023 | 1186 | 0.130 |
Why?
|
Time Factors | 16 | 2020 | 40075 | 0.130 |
Why?
|
Adult | 20 | 2023 | 214055 | 0.130 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2020 | 789 | 0.130 |
Why?
|
Predictive Value of Tests | 9 | 2020 | 15076 | 0.130 |
Why?
|
Vascular Surgical Procedures | 3 | 2023 | 1475 | 0.130 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1224 | 0.130 |
Why?
|
Nonlinear Dynamics | 2 | 2016 | 502 | 0.130 |
Why?
|
Pyruvate Dehydrogenase Complex | 1 | 2015 | 57 | 0.120 |
Why?
|
NAD | 1 | 2018 | 593 | 0.120 |
Why?
|
Cardiac Imaging Techniques | 1 | 2017 | 269 | 0.120 |
Why?
|
Pericardial Effusion | 3 | 2002 | 247 | 0.120 |
Why?
|
Signal Processing, Computer-Assisted | 3 | 2018 | 1534 | 0.120 |
Why?
|
Stents | 1 | 2006 | 3280 | 0.120 |
Why?
|
Prognosis | 5 | 2022 | 29063 | 0.120 |
Why?
|
Coronary Disease | 5 | 2011 | 6077 | 0.120 |
Why?
|
Coronary Sinus | 1 | 2015 | 87 | 0.120 |
Why?
|
Blood Pressure Determination | 1 | 2018 | 634 | 0.120 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2015 | 96 | 0.120 |
Why?
|
Severity of Illness Index | 10 | 2021 | 15540 | 0.120 |
Why?
|
Echocardiography, Four-Dimensional | 1 | 2013 | 16 | 0.120 |
Why?
|
Blood Vessel Prosthesis | 1 | 1998 | 933 | 0.120 |
Why?
|
Perioperative Care | 2 | 2020 | 1002 | 0.120 |
Why?
|
Receptor, Endothelin A | 2 | 2010 | 58 | 0.110 |
Why?
|
Saphenous Vein | 2 | 2011 | 532 | 0.110 |
Why?
|
Preoperative Care | 3 | 2019 | 2250 | 0.110 |
Why?
|
Osteoclasts | 1 | 2017 | 729 | 0.110 |
Why?
|
Software | 4 | 2016 | 4443 | 0.110 |
Why?
|
Hospital Mortality | 4 | 2023 | 5317 | 0.110 |
Why?
|
Health Care Surveys | 1 | 2020 | 2453 | 0.110 |
Why?
|
Logistic Models | 6 | 2020 | 13408 | 0.110 |
Why?
|
Survival Rate | 4 | 2021 | 12788 | 0.110 |
Why?
|
Blood Glucose | 3 | 2017 | 6256 | 0.110 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1998 | 810 | 0.100 |
Why?
|
Gene Expression Regulation | 6 | 2018 | 12072 | 0.100 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2009 | 1116 | 0.100 |
Why?
|
Reference Values | 3 | 2017 | 4982 | 0.100 |
Why?
|
Apoptosis | 6 | 2020 | 9727 | 0.100 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 817 | 0.100 |
Why?
|
Sympathetic Nervous System | 1 | 2014 | 514 | 0.100 |
Why?
|
Endovascular Procedures | 2 | 2023 | 1979 | 0.100 |
Why?
|
Tricuspid Valve Stenosis | 1 | 2011 | 32 | 0.100 |
Why?
|
Immunoblotting | 4 | 2020 | 1682 | 0.100 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2011 | 129 | 0.100 |
Why?
|
Phantoms, Imaging | 1 | 2019 | 2480 | 0.100 |
Why?
|
STAT3 Transcription Factor | 1 | 2015 | 873 | 0.100 |
Why?
|
Up-Regulation | 1 | 2020 | 4217 | 0.100 |
Why?
|
Sex Factors | 2 | 2021 | 10397 | 0.100 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2012 | 282 | 0.090 |
Why?
|
Vasoconstrictor Agents | 2 | 2011 | 642 | 0.090 |
Why?
|
Thoracic Surgery | 1 | 2017 | 719 | 0.090 |
Why?
|
Substance P | 1 | 2011 | 335 | 0.090 |
Why?
|
Vasodilation | 3 | 2009 | 944 | 0.090 |
Why?
|
Energy Metabolism | 1 | 2001 | 2899 | 0.090 |
Why?
|
Blood Pressure | 2 | 2018 | 8554 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2133 | 0.090 |
Why?
|
Calcium | 2 | 2017 | 5756 | 0.090 |
Why?
|
Patient Selection | 6 | 2017 | 4215 | 0.090 |
Why?
|
Thoracic Injuries | 1 | 2012 | 272 | 0.090 |
Why?
|
Boston | 4 | 2020 | 9313 | 0.090 |
Why?
|
Intracellular Fluid | 1 | 1989 | 203 | 0.090 |
Why?
|
Oxygen | 1 | 2021 | 4189 | 0.080 |
Why?
|
Ultrasonography | 5 | 2015 | 5985 | 0.080 |
Why?
|
Diagnosis, Differential | 5 | 2018 | 12959 | 0.080 |
Why?
|
Myosin Light Chains | 1 | 2009 | 121 | 0.080 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2011 | 272 | 0.080 |
Why?
|
Angiostatins | 1 | 2008 | 67 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2017 | 3206 | 0.080 |
Why?
|
Myocardial Infarction | 3 | 2023 | 11727 | 0.080 |
Why?
|
Calcinosis | 1 | 2017 | 1499 | 0.080 |
Why?
|
Chi-Square Distribution | 5 | 2017 | 3508 | 0.080 |
Why?
|
Proteomics | 2 | 2013 | 3638 | 0.080 |
Why?
|
Heart Atria | 2 | 2011 | 1357 | 0.080 |
Why?
|
Body Fluids | 1 | 1989 | 319 | 0.080 |
Why?
|
Endostatins | 1 | 2008 | 174 | 0.080 |
Why?
|
Operating Rooms | 1 | 2014 | 817 | 0.080 |
Why?
|
Acute Kidney Injury | 2 | 2018 | 1972 | 0.080 |
Why?
|
Patient Discharge | 1 | 2020 | 3313 | 0.080 |
Why?
|
Catheter Ablation | 2 | 2012 | 2758 | 0.080 |
Why?
|
Extracellular Space | 1 | 1989 | 594 | 0.080 |
Why?
|
Mitochondria | 2 | 2018 | 3520 | 0.070 |
Why?
|
Creatine Kinase, MB Form | 1 | 2008 | 214 | 0.070 |
Why?
|
Vascular Patency | 1 | 2010 | 886 | 0.070 |
Why?
|
Swine | 6 | 2016 | 5917 | 0.070 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2013 | 686 | 0.070 |
Why?
|
Coronary Angiography | 5 | 2013 | 4577 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2014 | 11725 | 0.070 |
Why?
|
Graft Occlusion, Vascular | 1 | 2010 | 549 | 0.070 |
Why?
|
Comorbidity | 2 | 2020 | 10388 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 5 | 2017 | 6538 | 0.070 |
Why?
|
Natriuretic Agents | 1 | 2006 | 25 | 0.070 |
Why?
|
Case-Control Studies | 6 | 2017 | 21746 | 0.070 |
Why?
|
Reoperation | 5 | 2017 | 4201 | 0.070 |
Why?
|
Device Removal | 1 | 2011 | 656 | 0.070 |
Why?
|
Follow-Up Studies | 9 | 2023 | 39050 | 0.070 |
Why?
|
Anesthesia, General | 1 | 2013 | 1171 | 0.070 |
Why?
|
Activities of Daily Living | 3 | 2020 | 2418 | 0.070 |
Why?
|
Jugular Veins | 1 | 2007 | 204 | 0.070 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2009 | 1504 | 0.070 |
Why?
|
Recurrence | 4 | 2020 | 8340 | 0.070 |
Why?
|
Entropy | 2 | 2018 | 209 | 0.070 |
Why?
|
Wounds, Nonpenetrating | 1 | 2012 | 794 | 0.070 |
Why?
|
Preoperative Period | 2 | 2018 | 549 | 0.060 |
Why?
|
Cardiac Output, Low | 1 | 2006 | 195 | 0.060 |
Why?
|
Anesthesiology | 1 | 2015 | 1060 | 0.060 |
Why?
|
Anticoagulants | 1 | 2020 | 4599 | 0.060 |
Why?
|
Systole | 2 | 2018 | 958 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2014 | 1390 | 0.060 |
Why?
|
Coronary Aneurysm | 1 | 2007 | 237 | 0.060 |
Why?
|
Canada | 2 | 2020 | 2065 | 0.060 |
Why?
|
Capillaries | 1 | 2007 | 773 | 0.060 |
Why?
|
Pulmonary Veins | 1 | 2010 | 761 | 0.060 |
Why?
|
Arteries | 2 | 2014 | 1119 | 0.060 |
Why?
|
Endarterectomy, Carotid | 2 | 2001 | 546 | 0.060 |
Why?
|
Animals | 12 | 2021 | 168757 | 0.060 |
Why?
|
Chemokines | 1 | 2008 | 970 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2017 | 4479 | 0.060 |
Why?
|
Tachycardia, Ventricular | 1 | 2012 | 1273 | 0.060 |
Why?
|
Quality of Life | 3 | 2019 | 12804 | 0.060 |
Why?
|
Ultrasonography, Interventional | 2 | 2010 | 1486 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 6770 | 0.050 |
Why?
|
United States | 10 | 2022 | 69872 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 916 | 0.050 |
Why?
|
Cognition Disorders | 2 | 2006 | 4043 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2001 | 2557 | 0.050 |
Why?
|
Microarray Analysis | 2 | 2017 | 767 | 0.050 |
Why?
|
Models, Statistical | 2 | 2014 | 5102 | 0.050 |
Why?
|
Rabbits | 1 | 2008 | 4894 | 0.050 |
Why?
|
DNA | 1 | 2015 | 7301 | 0.050 |
Why?
|
Decontamination | 1 | 2021 | 69 | 0.050 |
Why?
|
Surgical Instruments | 1 | 2023 | 395 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 1434 | 0.050 |
Why?
|
Genetic Testing | 1 | 2013 | 3444 | 0.050 |
Why?
|
Cohort Studies | 7 | 2020 | 40561 | 0.050 |
Why?
|
Prevalence | 3 | 2019 | 15226 | 0.050 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 2 | 2011 | 68 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10262 | 0.050 |
Why?
|
Receptor, Endothelin B | 2 | 2010 | 41 | 0.050 |
Why?
|
Ventricular Function, Left | 2 | 2023 | 3670 | 0.050 |
Why?
|
Coronary Stenosis | 1 | 2006 | 834 | 0.050 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1107 | 0.050 |
Why?
|
Immunohistochemistry | 4 | 2017 | 11366 | 0.040 |
Why?
|
Stroke Volume | 2 | 2023 | 5007 | 0.040 |
Why?
|
DNA Methylation | 1 | 2014 | 4286 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2010 | 8642 | 0.040 |
Why?
|
Coronary Vessel Anomalies | 1 | 2003 | 314 | 0.040 |
Why?
|
Electrodes | 1 | 2001 | 619 | 0.040 |
Why?
|
Signal Transduction | 3 | 2015 | 23403 | 0.040 |
Why?
|
Endothelium, Vascular | 2 | 2009 | 4456 | 0.040 |
Why?
|
Models, Biological | 1 | 2016 | 9583 | 0.040 |
Why?
|
Paclitaxel | 1 | 2006 | 1708 | 0.040 |
Why?
|
Time | 1 | 2021 | 542 | 0.040 |
Why?
|
Intermediate-Conductance Calcium-Activated Potassium Channels | 2 | 2009 | 44 | 0.040 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channels | 2 | 2009 | 32 | 0.040 |
Why?
|
Diastole | 2 | 2018 | 791 | 0.040 |
Why?
|
Odds Ratio | 3 | 2017 | 9849 | 0.040 |
Why?
|
Pentosyltransferases | 1 | 2018 | 65 | 0.040 |
Why?
|
Quinolinic Acid | 1 | 2018 | 67 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2022 | 417 | 0.040 |
Why?
|
Patient Care Team | 1 | 2010 | 2531 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 13033 | 0.040 |
Why?
|
Sheep | 1 | 2001 | 1437 | 0.040 |
Why?
|
Shock, Cardiogenic | 1 | 2023 | 688 | 0.040 |
Why?
|
Thrombosis | 1 | 2012 | 2968 | 0.040 |
Why?
|
Blotting, Western | 3 | 2015 | 5179 | 0.040 |
Why?
|
France | 1 | 2019 | 517 | 0.040 |
Why?
|
Peptides, Cyclic | 2 | 2010 | 400 | 0.040 |
Why?
|
Fibrosis | 2 | 2016 | 2029 | 0.040 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2006 | 1573 | 0.040 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2017 | 72 | 0.040 |
Why?
|
Brain Diseases | 1 | 2006 | 1563 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12245 | 0.040 |
Why?
|
Oximes | 2 | 2008 | 311 | 0.040 |
Why?
|
Pilot Projects | 3 | 2018 | 8324 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4567 | 0.040 |
Why?
|
Quebec | 1 | 2016 | 134 | 0.040 |
Why?
|
Apoptotic Protease-Activating Factor 1 | 1 | 2016 | 23 | 0.040 |
Why?
|
Skilled Nursing Facilities | 1 | 2020 | 372 | 0.030 |
Why?
|
Swine, Miniature | 2 | 2009 | 961 | 0.030 |
Why?
|
Tryptophan | 1 | 2018 | 478 | 0.030 |
Why?
|
Niacinamide | 1 | 2018 | 417 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2017 | 290 | 0.030 |
Why?
|
Hematoma | 1 | 2001 | 758 | 0.030 |
Why?
|
Smad1 Protein | 1 | 2016 | 81 | 0.030 |
Why?
|
RANK Ligand | 1 | 2017 | 326 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2001 | 2726 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3778 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2021 | 12026 | 0.030 |
Why?
|
Perception | 1 | 2021 | 1198 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2018 | 822 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2009 | 3336 | 0.030 |
Why?
|
Subclavian Artery | 1 | 2014 | 130 | 0.030 |
Why?
|
Atrial Function, Left | 1 | 2015 | 173 | 0.030 |
Why?
|
Carotid Stenosis | 1 | 2001 | 854 | 0.030 |
Why?
|
Caspase 3 | 1 | 2016 | 758 | 0.030 |
Why?
|
Proteins | 1 | 2008 | 6103 | 0.030 |
Why?
|
Glucose Transporter Type 4 | 1 | 2013 | 250 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 697 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2014 | 898 | 0.030 |
Why?
|
Autophagy | 1 | 2020 | 1300 | 0.030 |
Why?
|
Epicardial Mapping | 1 | 2012 | 57 | 0.030 |
Why?
|
Skin Temperature | 1 | 1992 | 93 | 0.030 |
Why?
|
Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2011 | 9 | 0.030 |
Why?
|
Thromboxane-A Synthase | 1 | 2011 | 34 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 1654 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2017 | 1641 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2014 | 597 | 0.030 |
Why?
|
Hypertrophy | 1 | 2013 | 569 | 0.030 |
Why?
|
Acute Disease | 2 | 2014 | 7149 | 0.030 |
Why?
|
Wound Infection | 1 | 2014 | 242 | 0.030 |
Why?
|
Suture Techniques | 1 | 2016 | 798 | 0.020 |
Why?
|
Myocardial Reperfusion | 2 | 2008 | 351 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2016 | 2274 | 0.020 |
Why?
|
Constriction | 1 | 2010 | 181 | 0.020 |
Why?
|
Atrial Septum | 1 | 2011 | 60 | 0.020 |
Why?
|
Type C Phospholipases | 1 | 2011 | 292 | 0.020 |
Why?
|
Receptors, Endothelin | 1 | 2010 | 58 | 0.020 |
Why?
|
Circulatory Arrest, Deep Hypothermia Induced | 1 | 2010 | 76 | 0.020 |
Why?
|
Electrocardiography | 3 | 2011 | 6442 | 0.020 |
Why?
|
Quality Improvement | 2 | 2017 | 3749 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2013 | 940 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4420 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2004 | 3110 | 0.020 |
Why?
|
Surgical Staplers | 1 | 2010 | 34 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 2000 | 1540 | 0.020 |
Why?
|
Young Adult | 5 | 2018 | 56430 | 0.020 |
Why?
|
Heart Defects, Congenital | 1 | 2007 | 4584 | 0.020 |
Why?
|
Ganglia, Autonomic | 1 | 2010 | 43 | 0.020 |
Why?
|
Indoles | 2 | 2008 | 1839 | 0.020 |
Why?
|
Endoscopy | 1 | 2000 | 1785 | 0.020 |
Why?
|
Alloxan | 1 | 2009 | 13 | 0.020 |
Why?
|
CpG Islands | 1 | 2014 | 1172 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2016 | 1869 | 0.020 |
Why?
|
Myosin-Light-Chain Phosphatase | 1 | 2009 | 20 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2684 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16365 | 0.020 |
Why?
|
Cresols | 1 | 2008 | 28 | 0.020 |
Why?
|
Apamin | 1 | 2008 | 23 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2001 | 3279 | 0.020 |
Why?
|
Small-Conductance Calcium-Activated Potassium Channels | 1 | 2008 | 45 | 0.020 |
Why?
|
Vasomotor System | 1 | 2009 | 209 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3527 | 0.020 |
Why?
|
Age Factors | 3 | 2016 | 18370 | 0.020 |
Why?
|
Dogs | 2 | 1993 | 3912 | 0.020 |
Why?
|
Sphingosine | 1 | 2010 | 307 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2013 | 18029 | 0.020 |
Why?
|
Potassium Channel Blockers | 1 | 2008 | 171 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 2007 | 0.020 |
Why?
|
Hemorrhage | 1 | 2020 | 3461 | 0.020 |
Why?
|
Aneurysm | 1 | 2011 | 339 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5952 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3396 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 1993 | 1585 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6171 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2015 | 1403 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3584 | 0.020 |
Why?
|
Chronic Disease | 2 | 2013 | 9146 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2864 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2010 | 987 | 0.020 |
Why?
|
Genetic Markers | 1 | 2013 | 2634 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10943 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2013 | 2715 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2010 | 413 | 0.020 |
Why?
|
Peptides | 2 | 2008 | 4409 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2016 | 1956 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5524 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2012 | 964 | 0.020 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2010 | 845 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2008 | 472 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2010 | 517 | 0.020 |
Why?
|
Leukocytes | 1 | 2014 | 2043 | 0.020 |
Why?
|
Algorithms | 2 | 2018 | 13881 | 0.020 |
Why?
|
Fatty Acids | 1 | 2013 | 1809 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1970 | 0.020 |
Why?
|
Potassium Channels | 1 | 2008 | 563 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2008 | 528 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 1988 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 1708 | 0.020 |
Why?
|
Oligopeptides | 1 | 2010 | 1189 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2008 | 638 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13989 | 0.020 |
Why?
|
Microvessels | 1 | 2009 | 544 | 0.020 |
Why?
|
Medicare | 1 | 2022 | 6566 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2008 | 977 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 643 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14722 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2759 | 0.010 |
Why?
|
Cell Membrane | 1 | 2013 | 3748 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2005 | 534 | 0.010 |
Why?
|
Incidence | 2 | 2019 | 20947 | 0.010 |
Why?
|
Cell Survival | 1 | 2013 | 5882 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2019 | 4371 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3327 | 0.010 |
Why?
|
Benzimidazoles | 1 | 2008 | 850 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2013 | 2635 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2007 | 2505 | 0.010 |
Why?
|
Carbon Monoxide | 1 | 2006 | 531 | 0.010 |
Why?
|
Heart Rate | 1 | 2014 | 4091 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2006 | 1263 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2007 | 1227 | 0.010 |
Why?
|
Piperidines | 1 | 2010 | 1602 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3920 | 0.010 |
Why?
|
Blood Platelets | 1 | 1992 | 2508 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2007 | 3701 | 0.010 |
Why?
|
Critical Care | 1 | 2014 | 2647 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8388 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2006 | 1200 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 2046 | 0.010 |
Why?
|
Registries | 1 | 2016 | 8089 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2007 | 2382 | 0.010 |
Why?
|
Echocardiography, Doppler | 1 | 2002 | 935 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7799 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2006 | 1738 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2003 | 1850 | 0.010 |
Why?
|
Pyrazoles | 1 | 2008 | 1972 | 0.010 |
Why?
|
Heart | 1 | 2011 | 4467 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2013 | 10481 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8436 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2008 | 5974 | 0.010 |
Why?
|
tau Proteins | 1 | 2006 | 1868 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2009 | 2872 | 0.010 |
Why?
|
Life Tables | 1 | 1996 | 370 | 0.010 |
Why?
|
Probability | 1 | 2001 | 2505 | 0.010 |
Why?
|
Aging | 1 | 2014 | 8664 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9438 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5535 | 0.010 |
Why?
|
Insulin | 1 | 2009 | 6580 | 0.010 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 1992 | 83 | 0.010 |
Why?
|
Bleeding Time | 1 | 1992 | 89 | 0.010 |
Why?
|
Thromboxane B2 | 1 | 1992 | 152 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2000 | 1359 | 0.010 |
Why?
|
Phosphocreatine | 1 | 1993 | 269 | 0.010 |
Why?
|
HIV Infections | 1 | 1998 | 16718 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17446 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81183 | 0.010 |
Why?
|
Research Design | 1 | 2007 | 5987 | 0.010 |
Why?
|
Platelet Function Tests | 1 | 1992 | 270 | 0.010 |
Why?
|
Carotid Artery Diseases | 1 | 1996 | 882 | 0.010 |
Why?
|
Phosphates | 1 | 1993 | 786 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 1993 | 1150 | 0.010 |
Why?
|
Survival Analysis | 1 | 2001 | 10252 | 0.000 |
Why?
|
Hypothermia, Induced | 1 | 1993 | 752 | 0.000 |
Why?
|
Adenosine Triphosphate | 1 | 1993 | 2025 | 0.000 |
Why?
|
Child | 1 | 2014 | 77709 | 0.000 |
Why?
|
Hypertension | 1 | 2006 | 8480 | 0.000 |
Why?
|
Aspirin | 1 | 1992 | 3282 | 0.000 |
Why?
|
Obesity | 1 | 2000 | 12745 | 0.000 |
Why?
|